CT GUIDED BIOPSY ( WITHOUT NEEDLE CHARGES) at Dr. Essa Lab

CT GUIDED BIOPSY ( WITHOUT NEEDLE CHARGES) at Dr. Essa Lab

The CT GUIDED BIOPSY ( WITHOUT NEEDLE CHARGES) at Dr. Essa Lab is a highly specialized, minimally invasive interventional radiology procedure designed to obtain precise tissue samples from deep-seated lesions within the body. By utilizing state-of-the-art computed tomography (CT) imaging, our expert interventional radiologists can visualize internal anatomical structures in real-time. This high-resolution, cross-sectional imaging allows for the precise guidance of a biopsy needle directly into the target tissue, minimizing damage to surrounding healthy organs, blood vessels, and nerves. The designation “without needle charges” indicates that the base cost of the procedure covers the advanced CT imaging, local anesthesia, radiologist fees, and nursing care, while the specialized disposable biopsy needle required for your specific procedure is billed separately or acquired based on the radiologist’s exact prescription.

CT-guided biopsies have revolutionized the field of diagnostic oncology and infectious disease medicine. Historically, obtaining tissue from deep thoracic, abdominal, or retroperitoneal lesions required open surgical exploration, which carried significant risks, prolonged hospital stays, and higher costs. Today, this outpatient procedure provides a highly accurate diagnostic yield with minimal patient discomfort and a rapid recovery time. The acquired tissue specimen is immediately preserved and sent to our accredited histopathology laboratory at Dr. Essa Lab, where consultant pathologists perform detailed microscopic, immunohistochemical, and molecular analyses to establish a definitive diagnosis. This seamless integration of advanced radiology and pathology is critical for formulating personalized treatment plans, particularly in cancer therapeutics.

Clinical Procedure: What to Expect

Patient Preparation

Proper patient preparation is vital to ensure safety, minimize the risk of complications, and guarantee the diagnostic quality of the biopsy specimen. Patients scheduled for a CT GUIDED BIOPSY ( WITHOUT NEEDLE CHARGES) at Dr. Essa Lab must adhere to the following clinical guidelines:

• Coagulation Profile: Patients must undergo blood tests, including Prothrombin Time (PT), Activated Partial Thromboplastin Time (APTT), and International Normalized Ratio (INR), along with a Complete Blood Count (CBC) to assess platelet levels. These tests must be performed within one week of the procedure to rule out bleeding diathesis.
• Medication Adjustments: Antiplatelet medications (such as aspirin, clopidogrel) and anticoagulants (such as warfarin, heparin, or novel oral anticoagulants) must be discontinued under the strict supervision of the prescribing physician, typically 5 to 7 days prior to the biopsy.
• Fasting Requirements: Patients are instructed to fast (nil per os) for at least 4 to 6 hours before the scheduled procedure. This is particularly important if conscious sedation is planned or if intravenous contrast media is required for lesion localization.
• Hydration and Renal Function: If contrast-enhanced CT guidance is utilized, a recent serum creatinine test is required to evaluate renal function, especially in diabetic patients or those with pre-existing kidney disease.
• Allergy History: Any history of allergic reactions to local anesthetics (like lidocaine), iodine-based contrast agents, or latex must be communicated to the clinical team beforehand.
• Accompanying Adult: Patients must arrange for a responsible adult to accompany them home after the procedure, as mild sedatives or local anesthetics may temporarily impair reflexes.

During the Procedure

The CT-guided biopsy is performed in a dedicated interventional CT suite under strict aseptic conditions. The procedure follows a highly structured clinical protocol:

• Patient Positioning: The patient is positioned on the CT scanner table in a supine, prone, or lateral decubitus position, depending on the anatomical location of the target lesion. Comfort is prioritized, as the patient must remain completely still during the scan.
• Initial Planning Scan: A preliminary, low-dose CT scan is performed to localize the lesion, plan the safest needle trajectory, and mark the optimal entry point on the patient’s skin.
• Sterilization and Anesthesia: The skin at the entry site is thoroughly cleansed with an antiseptic solution (such as chlorhexidine) and draped. A local anesthetic (typically 1% or 2% lidocaine) is infiltrated into the skin and subcutaneous tissues down to the level of the deep fascia or pleural/peritoneal lining to ensure a painless experience.
• Needle Insertion and Guidance: The interventional radiologist makes a tiny skin nick and advances the biopsy needle along the pre-planned path. Intermittent, quick CT scans are performed to verify the precise position of the needle tip within the target lesion.
• Specimen Collection: Once the needle tip is confirmed to be within the lesion, tissue cores or fluid aspirates are obtained using a specialized biopsy gun or aspiration syringe. Multiple passes may be performed to ensure adequate sample volume for histopathological and cytological analysis.
• Post-Procedure Scan and Monitoring: After removing the needle, pressure is applied to the site, and a sterile dressing is placed. A final CT scan is often performed to check for immediate complications, such as a pneumothorax (in lung biopsies) or a hematoma (in abdominal biopsies). The patient is then monitored in a recovery area for 2 to 4 hours.

When is a CT GUIDED BIOPSY ( WITHOUT NEEDLE CHARGES) Performed?

Evaluation of Suspicious Pulmonary Nodules and Masses

Physicians frequently request a CT-guided lung biopsy when routine chest X-rays or diagnostic CT scans reveal suspicious, indeterminate pulmonary nodules or peripheral lung masses. This procedure is critical for differentiating between primary lung malignancies (such as adenocarcinoma or squamous cell carcinoma), metastatic lesions originating from other organs, and benign inflammatory conditions like tuberculosis or fungal infections. The high spatial resolution of CT imaging allows the radiologist to safely navigate past major pulmonary blood vessels and the chest wall, obtaining high-quality tissue samples from nodules as small as one centimeter, thereby facilitating early oncological intervention.

Characterization of Focal Hepatic Lesions

CT-guided liver biopsy is indicated when non-invasive imaging studies, such as ultrasound, MRI, or triphasic CT, cannot definitively characterize a focal liver mass. This is particularly crucial in patients with chronic liver diseases, such as hepatitis B or C, or cirrhosis, who are at a high risk of developing hepatocellular carcinoma (HCC). It is also performed to investigate suspected metastatic disease in patients with known primary cancers of the colon, breast, or pancreas. The biopsy helps confirm the histological subtype and molecular markers of the tumor, which directly influences the selection of targeted therapies, immunotherapies, or surgical resection options.

Investigation of Indeterminate Renal and Adrenal Masses

Lesions located within the kidneys or adrenal glands often present diagnostic challenges on standard imaging. A CT-guided biopsy is performed to evaluate solid renal masses when there is clinical suspicion of renal cell carcinoma, lymphoma, or metastatic disease, especially in patients who are not ideal candidates for immediate surgery. Similarly, adrenal masses—particularly in patients with a history of extra-adrenal malignancy—are biopsied to distinguish between benign adrenal adenomas, primary adrenal cortical carcinomas, and metastatic deposits, ensuring that patients receive the most appropriate medical or surgical management.

Diagnosis of Deep Retroperitoneal and Pelvic Lymphadenopathy

Enlarged lymph nodes or soft tissue masses within the deep retroperitoneum or pelvic cavity are challenging to access using ultrasound due to overlying bowel gas. CT-guided biopsy provides an exceptionally safe and direct pathway to these deep structures. This is highly valuable for diagnosing hematological malignancies like Hodgkin and Non-Hodgkin lymphoma, staging pelvic cancers (such as cervical, prostate, or ovarian cancer), and identifying deep-seated infectious processes or retroperitoneal fibrosis, allowing clinicians to initiate targeted systemic therapies without resorting to invasive diagnostic laparoscopy.

Assessment of Musculoskeletal and Bone Lesions

CT-guided bone biopsy is the gold standard for evaluating osteolytic, osteoblastic, or mixed bone lesions that are suspicious for primary bone sarcomas (like osteosarcoma or Ewing sarcoma), metastatic disease, or infectious osteomyelitis. Because bone tissue is dense, CT guidance is essential to identify areas of cortical destruction or soft tissue extension where a biopsy needle can successfully penetrate. The resulting tissue sample allows pathologists to differentiate between neoplastic processes and chronic bone infections, guiding orthopaedic oncologists in planning limb-salvage surgeries or targeted radiotherapy.

What Does a CT GUIDED BIOPSY ( WITHOUT NEEDLE CHARGES) Detect?

A CT-guided biopsy, followed by comprehensive histopathological evaluation at Dr. Essa Lab, can detect a wide array of neoplastic, inflammatory, and infectious conditions, including:

• Adenocarcinoma of the Lung: The most common type of lung cancer, characterized by glandular differentiation.
• Squamous Cell Lung Carcinoma: A malignant epithelial tumor linked strongly to smoking history.
• Small Cell Lung Cancer: A highly aggressive neuroendocrine tumor requiring rapid systemic chemotherapy.
• Hepatocellular Carcinoma: Primary liver cancer arising in the setting of chronic cirrhosis or viral hepatitis.
• Cholangiocarcinoma: Malignant tumor originating from the intrahepatic bile duct epithelium.
• Metastatic Adenocarcinoma: Secondary tumor deposits in organs like the liver, lungs, or bones, originating from primary sites like the colon, breast, or prostate.
• Renal Cell Carcinoma: Primary kidney cancer, including clear cell, papillary, and chromophobe subtypes.
• Adrenal Cortical Carcinoma: A rare, highly malignant tumor of the adrenal cortex.
• Benign Adrenal Adenoma: A non-cancerous tumor of the adrenal gland, often found incidentally.
• Non-Hodgkin Lymphoma: Malignant proliferation of lymphoid cells within deep retroperitoneal or pelvic lymph nodes.
• Hodgkin Lymphoma: Characterized by the presence of diagnostic Reed-Sternberg cells in biopsied lymph nodes.
• Pulmonary Tuberculosis: Detected via caseating granulomatous inflammation and positive acid-fast bacilli (AFB) staining.
• Aspergillosis: A fungal infection characterized by acute-angle branching hyphae in tissue samples.
• Pyogenic Liver Abscess: Localized bacterial infection within the liver parenchyma, confirmed by purulent material and culture.
• Sarcoidosis: A systemic inflammatory disease characterized by non-caseating granulomas in multiple organs.
• Osteosarcoma: A primary malignant bone tumor characterized by the production of osteoid by neoplastic osteoblasts.
• Ewing Sarcoma: A highly malignant round-cell bone tumor primarily affecting children and young adults.
• Osteomyelitis: Acute or chronic bacterial infection of the bone marrow and cortical bone.
• Pancreatic Ductal Adenocarcinoma: Highly aggressive malignancy of the exocrine pancreas.
• Gastrointestinal Stromal Tumor (GIST): Mesenchymal tumor of the gastrointestinal tract or retroperitoneum, positive for CD117.
• Retroperitoneal Liposarcoma: A malignant tumor of fat cells located in the retroperitoneal space.
• Desmoid Tumor: Locally aggressive, non-metastasizing fibromatous tumor of soft tissues.
• Focal Nodular Hyperplasia: A benign, regenerative liver lesion characterized by a central stellate scar.
• Hepatic Hemangioma: A benign vascular liver lesion, occasionally biopsied if atypical on non-contrast imaging.
• Chronic Interstitial Nephritis: Inflammatory changes in the renal interstitium, diagnosed via core biopsy.

Turnaround Time and Report Access at Dr. Essa Lab

At Dr. Essa Lab, we understand that waiting for biopsy results can be an anxious time for patients and their families. The CT-guided biopsy procedure itself is completed within 30 to 60 minutes, after which the patient is monitored and discharged. The collected tissue specimen is immediately placed in a preservative solution (10% neutral buffered formalin) and transported to our central histopathology laboratory under strict chain-of-custody protocols.

The histopathological processing, which involves tissue dehydration, paraffin embedding, microtome sectioning, hematoxylin and eosin (H&E) staining, and expert microscopic evaluation by our consultant pathologists, typically takes 3 to 5 working days. In complex cases where specialized immunohistochemistry (IHC) stains or molecular testing (such as EGFR, ALK, or PD-L1 testing for lung cancer) are required to determine the precise tumor subtype, the final report may take up to 7 working days. Patients can easily access their diagnostic reports online through the secure Dr. Essa Lab patient portal, via our dedicated mobile application, or by visiting any of our convenient diagnostic centers across Karachi and other major cities.

CT GUIDED BIOPSY ( WITHOUT NEEDLE CHARGES) Findings Overview

The following table provides an overview of the anatomical structures evaluated during a CT-guided biopsy, along with typical normal and abnormal findings:

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Lung Parenchyma	Normal alveoli, thin-walled septa, absence of atypical cells or granulomas.	Adenocarcinoma, squamous cell carcinoma, caseating granulomas (tuberculosis), fungal hyphae.
Liver Tissue	Normal hepatic lobules, intact portal triads, absence of cellular atypia or fibrosis.	Hepatocellular carcinoma, metastatic adenocarcinoma, hepatic steatosis, cirrhosis, pyogenic abscess.
Kidney Parenchyma	Normal glomeruli, renal tubules, and interstitium without atypical cellular infiltrates.	Renal cell carcinoma, oncocytoma, chronic interstitial nephritis, metastatic deposits.
Adrenal Gland	Normal lipid-rich cortical cells and medullary tissue without nodular hyperplasia.	Adrenal cortical carcinoma, benign adenoma, pheochromocytoma, metastatic disease.
Retroperitoneal Lymph Nodes	Normal lymphoid architecture, intact sinuses, absence of malignant cells.	Hodgkin or Non-Hodgkin lymphoma, metastatic carcinoma, granulomatous lymphadenitis.
Bone and Skeletal Structure	Normal trabecular bone, osteocytes, and hematopoietic marrow elements.	Osteosarcoma, Ewing sarcoma, metastatic osteolytic lesions, chronic osteomyelitis.
Soft Tissue / Retroperitoneum	Normal skeletal muscle, adipose tissue, and fibrous connective tissue.	Liposarcoma, leiomyosarcoma, desmoid tumor, retroperitoneal fibrosis.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Dr. Essa Lab for CT GUIDED BIOPSY ( WITHOUT NEEDLE CHARGES)?

• Expert Interventional Radiologists: Our procedures are performed by highly trained, board-certified interventional radiologists with extensive experience in image-guided interventions.
• Advanced CT Technology: We utilize state-of-the-art, low-dose CT scanners that provide exceptional spatial resolution while minimizing radiation exposure to the patient.
• Integrated Histopathology Lab: Dr. Essa Lab features a fully accredited, high-tech pathology division, ensuring seamless, rapid, and accurate processing of biopsy specimens.
• Strict Sterile Protocols: We maintain the highest standards of infection control and sterile techniques in our dedicated interventional suites to ensure patient safety.
• Comprehensive Patient Care: From pre-procedure counseling to post-biopsy recovery and monitoring, our clinical team provides compassionate, patient-focused care.
• Transparent Pricing Structure: Our “without needle charges” option ensures that patients only pay for the exact specialized equipment required for their unique clinical case.
• Convenient Locations: With an extensive network of diagnostic centers across Karachi and Pakistan, accessing high-quality diagnostic care is easy and convenient.
• Legacy of Trust: Established in 1987, Dr. Essa Lab is a household name in Pakistan, recognized for diagnostic accuracy, reliability, and commitment to healthcare excellence.